ABBOTT ANNOUNCES GROUNDBREAKING NEW TRIAL IN STROKE PREVENTION

Abbott will begin enrolling patients during the first quarter of 2005 in its asymptomatic carotid trial, ACT I. The first trial of its kind, this multicenter, randomized trial will compare carotid artery stenting to carotid artery surgery in asymptomatic patients -- those who have not displayed symptoms of a stroke but are at-risk -- who normally would be referred for surgery.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18717820&full=1)